...
机译:含有Sorafenib的方案的优异的抢救治疗用于在Allo-HSCT后用FLT3-ITD复发急性髓性白血病
Southern Med Univ Nanfang Hosp Dept Hematol Guangzhou Guangdong Peoples R China;
Peking Univ Beijing Key Lab Hematopoiet Stem Cell Transplanta Peoples Hosp Inst Hematol;
Soochow Univ Affiliated Hosp 1 Suzhou Peoples R China;
Peking Union Med Coll Hematopoiet Stem Cell Transplantat Ctr Inst Hematol Tianjin Peoples R;
Third Mil Med Univ Xinqiao Hosp Dept Hematol Chongqing Peoples R China;
Southern Med Univ Zhujiang Hosp Dept Hematol Guangzhou Guangdong Peoples R China;
Southern Med Univ Zhujiang Hosp Dept Hematol Guangzhou Guangdong Peoples R China;
Southern Med Univ First Peoples Hosp Chenzhou Dept Hematol Chenzhou Peoples R China;
Southern Med Univ Nanfang Hosp Dept Hematol Guangzhou Guangdong Peoples R China;
Southern Med Univ Nanfang Hosp Dept Hematol Guangzhou Guangdong Peoples R China;
Soochow Univ Affiliated Hosp 1 Suzhou Peoples R China;
Southern Med Univ Nanfang Hosp Dept Hematol Guangzhou Guangdong Peoples R China;
Third Mil Med Univ Xinqiao Hosp Dept Hematol Chongqing Peoples R China;
Peking Union Med Coll Hematopoiet Stem Cell Transplantat Ctr Inst Hematol Tianjin Peoples R;
Soochow Univ Affiliated Hosp 1 Suzhou Peoples R China;
Peking Univ Peoples Hosp Inst Hematol Beijing Key Lab Hematopoiet Stem Cell Transplanta Beijing;
Southern Med Univ Nanfang Hosp Dept Hematol Guangzhou Guangdong Peoples R China;
机译:含有Sorafenib的方案的优异的抢救治疗用于在Allo-HSCT后用FLT3-ITD复发急性髓性白血病
机译:索拉非尼治疗复发性和难治性FLT3-ITD阳性急性髓性白血病:一种新的治疗选择
机译:同种异体造血干细胞移植后复发的FLT3-ITD急性髓细胞白血病中对索拉非尼的血液学反应高发生率
机译:砷救生优于化疗和骨髓移植复发急性突出细胞细胞白血病:来自香港的十年经验
机译:FLT3抑制剂对FLT3-ITD突变急性髓性白血病标准治疗的比较
机译:索拉非尼在干细胞移植之前和移植后复发之后对FLT3-ITD急性髓细胞性白血病患者具有耐受性并改善其临床结局
机译:索拉非尼治疗FLT3-ITD(+)急性骨髓性白血病:良好的初始结果以及与D835突变相关的后续无反应性的机制